- 1、本文档共42页,可阅读全部内容。
- 2、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。
- 3、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载。
- 4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
查看更多
78%患者CRT治疗有效 CRT改善慢性房颤患者心功能 Kiès et al.Heart 2006;92: 490-494 CRT逆转房颤患者LV/LA结构重塑 Kiès et al.Heart 2006;92: 490-494 CRT对持续性房颤维持窦律的作用 例数 CRT治疗6个月后7%患者电复律后保持窦性心律 Kiès et al.Heart 2006;92: 490-494 CRT-P/CRT-D术中是否对房颤患者需植入右心房导线? 尚无相应的循证及指南; 对阵发房颤者,应予植入右心房导线; 对于持续房颤或慢性房颤者,应根据具体情况而定:如具CRT适应证、房颤病程不长、左房内径未严重扩大及总体状况尚可,估计有复律可能者,可考虑植入;否则无需植入。 3、房颤:ICD及相关注意事项 DFT测试中AF转复发生率? Permanent AF was noted in 12% of our patients undergoing ICD implantation, and SR return following defibrillation to terminate VF during testing after ICD implantation was seen in 36% of patients who underwent this test. N=671 Kardiologia Polska. 2011; 69, 1: 17–22 DFT测试与AF转复预测因子 Kardiologia Polska. 2011; 69, 1: 17–22 1.双线圈除颤导线 2.心功能 3.左房尺寸 4.胺碘酮 DFT测试:存在AF转复的可能 注意事项: 对AF需植入ICD的患者是否需抗凝及能否耐受术前的一些检查; 术前抗凝治疗?(时间?INR?) 术前检查?(TEE?CT?) ICD放电的常见原因 MADIT II. J Am Coll Cardiol. April 2008;51(14):1357-1365. Poster: Poole JE, et al. Analysis of ICD Shock Electrograms in the SCD-HeFT Trial. Heart Rhythm Society Conference. 2004. SVT中房颤是重要的房性心律失常,是引起ICD不恰当放电的常见原因之一,对于基础心律为窦性或有阵发房颤者选择双腔或单导线VDD除颤器可能可减少不恰当放电的发生率。 双腔ICD:提高阵发房颤的诊断能力 单导线VDD除颤器:提高房性心律失常的鉴别诊断能力 小 结 1、对于房颤或阵发房颤患者:抗心动过缓起搏器治疗选择主要为适应证、起搏方式及术后房性心律失常的监测管理; 2、CRT和ICD:有房颤患者适应证的选择及相应的注意事项。 谢 谢! * * BACKGROUND: Atrial fibrillation/flutter (AF) and heart failure often coexist; however, the effect of cardiac resynchronization therapy (CRT) on the incidence of AF and on the outcome of patients with new-onset AF remains undefined. METHODS AND RESULTS: In the CArdiac REsynchronisation in Heart Failure (CARE-HF) trial, 813 patients with moderate or severe heart failure were randomly assigned to pharmacological therapy alone or with the addition of CRT. * The incidence of AF was assessed by adverse event reporting and by ECGs during follow-up, and the impact of new-onset AF on the outcome and efficacy of CRT was evaluated. By the end of the study (mean duration of follow-up 29.4 months), AF had been documented in 66 patients in the CRT group compared with 58 who
文档评论(0)